EUVIMEDEUVIMED entdecken
Crossref

A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database

Yuichi Uwai iD, Tomohiro Nabekura

Congenital Anomalies · 2024

DOI: 10.1111/cga.12579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Congenital Anomalies, 2024. Verfasst von Yuichi Uwai und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Aichi Gakuin University, Nagoya, Japan. Hauptthemen laut MEDLINE: Valproic Acid, Pharmacovigilance, Strabismus, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This pharmacovigilance study investigated the relationship between antiepileptic drugs and congenital strabismus, utilizing the FDA Adverse Event Report System database between 2014 and 2023. Out of 28 347 889 reports of adverse events in 10 937 764 cases, we identified 1104 reports of strabismus and 67 of congenital strabismus. Valproic acid was the most frequently implicated primary suspect drug (95 and 14 cases, respectively). Ninety‐five reports involved transplacental valproic acid exposure, yielding an information component (IC) of 7.06 (IC‐2 × standard deviation: 5.50). A multivariate analysis showed that transplacental exposure to valproic acid correlated with strabismus (adjusted odds ratio: 8.47, 95% CI: 6.74–10.65). We revealed a robust safety signal linking valproic acid to congenital strabismus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Valproic AcidPharmacovigilanceStrabismusAdverse Drug Reaction Reporting SystemsUnited States Food and Drug AdministrationAnticonvulsantsDatabases, FactualHumansUnited StatesFemaleMaleAdultPregnancyAdolescentInfantYoung AdultChildChild, Preschool

Stichwörter der Autor:innen

FAERS databasecongenital strabismussafety signaltransplacental routevalproic acid

Substanzen

Valproic AcidAnticonvulsants

Autor:innen und Institutionen

  • School of Pharmacy, Aichi Gakuin University, Nagoya, Japan.

ORCID-Profile: Yuichi Uwai

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Uwai, Y., & Nabekura, T. (2024). A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database. Congenital Anomalies. https://doi.org/10.1111/cga.12579

Vancouver

Uwai Y, Nabekura T. A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database. Congenital Anomalies. 2024. doi:10.1111/cga.12579

BibTeX
@article{Uwai2024,
  author = {Uwai, Yuichi and Nabekura, Tomohiro},
  title = {A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database},
  journal = {Congenital Anomalies},
  year = {2024},
  doi = {10.1111/cga.12579}
}
Kostenlos starten →